MDR1 Single Nucleotide Polymorphisms Predict Response to Vinorelbine-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer

Publisher： Karger

E-ISSN： 1423-0356|75|4|380-385

ISSN： 0025-7931

Source： Respiration, Vol.75, Iss.4, 2007-09, pp. : 380-385

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MDR1 Single Nucleotide Polymorphism G2677T/A and Haplotype Are Correlated with Response to Docetaxel-Cisplatin Chemotherapy in Patients with Non-Small-Cell Lung Cancer

By  

Respiration, Vol. 78, Iss. 1, 2008-09 ,pp. : 49-55

Karger

Access to resources Recommend Favorite

Vinorelbine-Based Regimens as Salvage Treatment in Patients with Advanced Non-Small Cell Lung Cancer: Two Parallel Multicenter Phase II Trials

By  

Oncology, Vol. 60, Iss. 3, 2001-04 ,pp. : 235-241

Karger

Access to resources Recommend Favorite

Role of DNA Repair Gene Polymorphisms in the Efficiency of Platinum-Based Adjuvant Chemotherapy for Non-Small Cell Lung Cancer

By Mathiaux Juliette   >  

Molecular Diagnosis & Therapy, Vol. 15, Iss. 3, 2011-06 ,pp. : 159-166

Adis International

Access to resources Recommend Favorite

Chemotherapy in Non-Small Cell Lung Cancer Patients Receiving Oxygen Therapy

By  

Oncology Research and Treatment, Vol. 39, Iss. 10, 2016-09 ,pp. : 587-590

Karger

Access to resources Recommend Favorite

Vinorelbine and Alternating Cisplatin and Ifosfamide in the Treatment of Non-Small Cell Lung Cancer

By  

Oncology, Vol. 58, Iss. 1, 2000-01 ,pp. : 25-30

Karger

Access to resources Recommend Favorite